Contact

Category: AstraZeneca

  • Israel’s Immunai expands strategic tie with AstraZeneca

    •

    Investor Empires

    Israeli company imperviousThe company, which develops artificial intelligence-based tools to improve drug discovery processes, has announced a strategic agreement with pharmaceutical company AstraZeneca. Immunai will receive $18 million from AstraZeneca in the initial phase of research, but the main importance of the deal is not the initial amount, but the…

  • AstraZeneca warns of moving UK vaccine production to US, FT reports By Reuters

    •

    Investor Empires

    (Reuters) – AstraZeneca has warned it may move vaccine manufacturing from the United Kingdom to the United States amid a standoff with the new Labour government over plans to cut state aid, the Financial Times reported on Thursday. UK finance minister Rachel Reeves wants to cut government funding for the…

  • Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2

    •

    Investor Empires

    Al-Naylam Pharmaceuticals CompanyNasdaq: ALLNEY) The best-performing large-cap company ($30+ billion) was in the pharmaceutical or biotechnology space in the second quarter, Yield ~58.5% In the period. The biotech company’s strong performance was helped significantly in late June when it announced strong pivotal trial results for vutrisiran, a treatment for ATTR…

  • AstraZeneca shares rise as pharma group unveils 2030 revenue target By Investing.com

    •

    Investor Empires

    Investing.com – UK-listed shares in AstraZeneca (LON:) rose in morning trade on Tuesday after the pharmaceutical giant announced a new revenue target of 2030. In a statement ahead of an investor event touting a “new era of growth,” AstraZeneca said it now expects to achieve total revenues of $80 billion…